Reply to Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma

Cancer. 2018 May 15;124(10):2254-2255. doi: 10.1002/cncr.31261. Epub 2018 Mar 15.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Brain Neoplasms*
  • Humans
  • Melanoma*
  • Neoplasm Staging
  • Proto-Oncogene Proteins B-raf
  • United States

Substances

  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf